Category: Pharmaceuticals
Global Pharmaceuticals
-
Kidney Stone Management Devices
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end ... Read More
-
Animal Medication
... CAGR of 4.5% over the analysis period 2024-2030. Companion Animals Medication, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$20.7 Billion by the end of the ... Read More
-
Pain Management Devices
... at a CAGR of 7.8% over the analysis period 2024-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Herbal Supplements and Remedies
... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Multi-Herb Supplements and Remedies, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$94.2 Billion ... Read More
-
Organic Foods and Beverages
... 2030, growing at a CAGR of 14.2% over the analysis period 2024-2030. Organic Fruits & Vegetables, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$258.8 Billion ... Read More
-
Radiation Therapy Equipment
... at a CAGR of 6.6% over the analysis period 2024-2030. External Beam Radiation Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.1 Billion by the ... Read More
-
Sepsis Therapeutics
... CAGR of 6.3% over the analysis period 2024-2030. Cephalosporin, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.1 Billion by the end of the analysis period. ... Read More
-
Synthetic Biology
... CAGR of 27.9% over the analysis period 2024-2030. Oligonucleotides & Synthetic DNA Tool, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$39.5 Billion by the end ... Read More
-
Dental Infection Control Products
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Dental Infection Control Consumables, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 Billion ... Read More
-
Automated Storage and Retrieval Systems (ASRS)
... reach US$13.4 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Unit Load ASRS, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and ... Read More
-
Computer Aided Engineering (CAE)
... 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Finite Element Analysis (FEA), one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$12.6 Billion ... Read More
-
Ginseng
... 10.2% over the analysis period 2024-2030. Asian Ginseng, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$11.2 Billion by the end of the analysis period. Growth ... Read More
-
Interventional Radiology Systems
... at a CAGR of 7.1% over the analysis period 2024-2030. MRI Systems, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.7 Billion by the end of ... Read More
-
OTT Devices and Services
... 2030, growing at a CAGR of 17.9% over the analysis period 2024-2030. Video Content, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$252.9 Billion by the ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Ophthalmic Lasers
... CAGR of 5.0% over the analysis period 2024-2030. Femtosecond Lasers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$757.4 Million by the end of the analysis ... Read More
-
Antidepressants
... 2.5% over the analysis period 2024-2030. Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end of the analysis period. ... Read More
-
Ophthalmic Pharmaceutical Drugs
... at a CAGR of 3.6% over the analysis period 2024-2030. Anti-VEGF Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$34.3 Billion by the end of ... Read More
-
Insulin Pumps
... CAGR of 7.0% over the analysis period 2024-2030. Tethered Pumps, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$15.0 Billion by the end of the analysis ... Read More
-
Intelligent Pumps
... CAGR of 6.1% over the analysis period 2024-2030. Centrifugal Pumps, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Invisible Orthodontics
... CAGR of 9.2% over the analysis period 2024-2030. Clear Aligners, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$5.5 Billion by the end of the analysis ... Read More
-
Nanosensors
... 58.6% over the analysis period 2024-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 61.3% CAGR and reach US$14.1 Billion by the end of the analysis period. Growth ... Read More
-
Ocular Implants
... CAGR of 4.2% over the analysis period 2024-2030. Glaucoma Implants, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$6.5 Billion by the end of the analysis ... Read More
-
Photography Equipment
... CAGR of -9.2% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a -10.4% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
Research Assistance
